Platform|API|Archive|Contact
Humanexa SignalsPharmaceutical Intelligence
Subscribe
Signals
Regulatory
  • FDA
  • EMA
  • MHRA
  • PMDA
  • Health Canada
Clinical
  • Phase I
  • Phase II
  • Phase III
  • Readouts
  • Enrollment Signals
Competitive
  • Pipeline Tracking
  • Company Moves
  • Asset Intelligence
  • Landscape Reports
Markets
  • Pricing
  • Access
  • Commercial
  • Launch Tracking
M&A Watch
  • Licensing
  • Acquisitions
  • Partnerships
  • Capital Raises
StrategyCatalystsPricing
Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

  • Regulatory
  • Clinical
  • Competitive
  • Markets
  • M&A Watch
  • Strategy
  • Catalyst Tracker

Company

  • Pricing
  • Partner with us
  • Subscribe
  • Contact
  • Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

Therapeutic Area

Medical Device

Therapeutic area intelligence for Medical Device with 4 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals
4
Catalysts
0
Companies
0

Companies

No related entities indexed yet.

Assets

Allurion →
GE →
Japet →
Medtronic →

Recent signals(4)

RegulatoryAugust 16, 2026

GE HealthCare Issues Early Alert for Infant Resuscitation System Oxygen Delivery Problem

GE HealthCare has issued an early alert regarding a potential safety issue with the air-oxygen blender knob shaft on certain integrated and stand-alone infant resuscitation systems.

CompetitiveJuly 14, 2026

Medtronic Recalls Harmony Delivery Catheter Due to Detachment Risk

Medtronic has recalled certain lots of the Harmony Delivery Catheter System due to a risk of the distal tip detaching.

RegulatoryJuly 13, 2026

Allurion Gastric Balloon Safety Update: Risks of Obstruction and Perforation

The Allurion Gastric Balloon may cause serious complications, including gastric outlet obstruction, small bowel obstruction, and gastric perforation.

CompetitiveJune 26, 2026

Japet Medical Devices Evaluates JAPET.W+ for Low Back Pain Management

The JAPET.W+ device is being assessed for its effectiveness in managing low back pain through a clinical trial.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

Obesity →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.